abstract |
In one aspect, compositions and thereapeutic use thereof are provided that can inhibit α-synuclein cell-to-cell transmission. In embodiment, methods are provided to treat a mammal such as a human that is suffering from or susceptible to an α-synucleinopathy that include administering to the mammal an effective amount of one or more metal nanozymes. |